- Research
- Resources
- Teaching
- Group
- Events
- News Archive
Type: Seminar (2 SWS)
Ects: 4.0
Lecturer: Burkhard Rost
Time: Monday, 12:15 - 13:45
Room: MI 01.09.034
Language: English
Topics related to the research interests of the group: protein sequence analysis, sequence based predictions,
protein structure prediction and analysis; interaction networks.
Monday, August 1, 2 pm
Topics were assigned during the pre-meeting as below.
24.10.2011 Nicolas Guirao: Protein (structure) family databases
Advisor: Andrea Schafferhans
31.10.2011 Hagen Fritsch: Protein design and engineering
Advisor: Marc Offman
07.11.2011 Simon Dirmeier: Homology-based annotation of protein function in silico
Advisor: Edda Kloppmann
14.11.2011 Julia-Sophie Heier: Analysing enzyme function using structures
Advisor: Andrea Schafferhans
21.11.2011 Julia Gerke: Prediction using Sequences, Structures and more
Advisor: Tobias Hamp
28.11.2011 Valentina Klaus: Prediction of functional effects of non-synonymous SNPs
Advisor: Shaila Roessle
05.12.2011 Maria Kalemanov: Disease Networks
Advisor: Arthur Dong
12.12.2011 Christoph Hamm: Genetic heterogeneity and disease
Advisor: Christian Schaefer
09.01.2011 Martin Steinegger: Application of cloud computing in bioinformatics
Advisor: Laszlo Kajan
Molecular Dynamics
Advisor: Marc Offman
Combining physical and genetic interaction networks
Advisor: Arthur Dong
Predicting regions with no regular structure (NORS)
Advisor: Esmeralda Vicedo
Dr. Marc Offman
Proteins are central to most biological processes and their spectrum of functions is seemingly endless. Given that proteins are found in almost any living forms and each organism had to adapt to evolutionary pressure over million of years, a large number of different proteins have evolved. Some of these proteins could potentially be used as drugs, others need to be adapted (engineered), and for some purposes new proteins need to be designed. In protein engineering/design either known proteins are adapted in order to meet certain criteria such as increased stability, function, activity and recognition, or novel protein folds are created. Given the fact that proteins are large, complicated molecules with a huge number of degrees of freedom, protein engineering seems to be an unsolvable task. Nevertheless, methods are under constant development and show some success, as engineered proteins can already be used as therapeutics and as tools for cell biology.
Reference
Lippow, A. M. and Tidor, B. (2007). Progress in computational protein design. Curr Opin Biotechnol, vol. 18 (4) pp. 305-311.
http://www.ncbi.nlm.nih.gov/pubmed/17644370
Kuhlman, B. et al. (2003). Design of a novel globular protein fold with atomic-level accuracy. Science, vol 302 (5649) pp. 1364-1368.
http://www.sciencemag.org/content/302/5649/1364.full.pdf
Rothlisberger D, Khersonsky O, Wollacott AM, et al. (2008). Kemp elimination catalysts by computational enzyme design. Nature. Vol 453(7192)pp. 190-195.
http://www.ncbi.nlm.nih.gov/pubmed/18354394?dopt=AbstractPlus
Jiang L, Althoff EA, Clemente FR, et al. (2008). De novo computational design of retro-aldol enzymes. Science, vol 319(5868), pp. 1387-1391.
http://www.ncbi.nlm.nih.gov/pubmed/18323453?dopt=AbstractPlus
Dr. Edda Kloppmann
The majority of known proteins has not yet been characterized experimentally. Annotating protein function in silico using available information on their sequence, their structure, their evolutionary history, and their association with other proteins will help to further the understanding of the known protein sequences. This talk should introduce gene ontologies and focus on the homolgy-based prediction of protein function.
Literature:
Annotating protein function is routinely done by transferring annotations from related sequences. However, this is a very crude annotation. This talk should give an introduction to methods that infer more specific information from a structural analysis of the active site.
Literature:
This is the third and final installment of a series of talks about the prediction of protein function in-silico. Whereas the first two focus on function prediction by sequence and structure, respectively, this talk is supposed to introduce so-called meta predictors, i.e. tools which combine sequence and structure information and/or make use of other data such as protein-protein interactions to annotate protein function.
Literature:
A number of databases collect classifications of proteins by structure and sequence families. This talk shall give an overview of the commonalities and differences of the most well-known of these databases: CATH, SCOP and Superfamily.
Literature:
Dr. Shaila Roessle
Single Nucleotide Polymorphisms (SNPs) represent a very large portion of all genetic variations. SNPs found in the coding regions of genes are often non-synonymous, changing a single amino acid in the encoded protein sequence. SNPs are either "neutral" in the sense that the resulting point-mutated protein is not functionally discernible from the wild-type, or they are "non-neutral" in that the mutant and wild-type differ in function. The ability to identify non-neutral substitutions in an ocean of SNPs could significantly aid targeting disease causing detrimental mutations, as well as SNPs that increase the fitness of particular phenotypes.
There are methods based on physical and comparative considerations that estimate the impact of an amino acid replacement on the three-dimensional structure and function of the protein.
Literature:
Dr. Arthur Dong
Molecular studies of diseases have traditionally focused on single genes (so called monogenic diseases). However, most common diseases are surprisingly complex, involving the interplay of multiple genes and proteins. The increasing availability of genome-scale data and the rise of systems biology ushered in a new era of network-based disease studies.
Literature:
The human disease network.PNAS 2007 May 22;104(21):8685-90
Dr. Arthur Dong
Proteins are the main molecular actors in a cell, but they rarely carry out their functions alone. Instead, they physically interact with each other in most biological processes. The physical interactions can be either permanent, as in protein complexes, or transient, as in signal transduction. Proteins can also be highly correlated without interacting with each other physically; for example, one protein may induce or suppress another protein, or two proteins may participate in the same pathway. Such indirect interactions are termed genetic interactions. Both physical and genetic interactions in a cell form complex networks, with intriguing properties. In this study we combine the two types of networks to obtain further insights.
Literature:
Dipl.-Bioinf. Christian Schaefer
How do mutations influence susceptibility to disease? How could relationships be found between genotype and phenotype? In this seminar general topics like GWAS, SNPs, genetic diseases and examples should be presented and discussed. Special emphasis should be placed on differences between neutral nsSNPs, disease-associated and cancer-related variants.
Methods:
Introduction:
Present an overview of the current state of continuous automated performance assessment solutions in bioinformatics.
Assorted references:
Diplom Biol. Esmeralda Vicedo
One common definition of regions of “disorder” in proteins is that they do not adopt a regular three-dimensional (3D)structure in isolation on their own. These disordered regions are in contrast to regions that are well structured or “ordered”. Notably, there is a great variety of “flavors” of disorder: some adopt a unique regular 3D secondary structure only upon binding; others, for example loops, remain irregular; some proteins are almost entirely disordered and others have only short disordered region. Numerous computational methods exist that predict disorder based on a variety of concepts. One of these methods, Norsnet has been developed in our group. Norsnet uses a neural network to predict disordered regions of the “loopy” type (unstructured loops), important regions for network complexity.
Literature: